Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Dietary Interventions in the Secondary Prevention of Myocardial Infarction: Focus on Plant-Based Nutrition (PBN in IM)

4. maj 2026 opdateret af: Radana Dymáčková

The Role of Diet in the Secondary Prevention of Myocardial Infarction, With a Focus on a Plant-Based Diet

The goal of this clinical trial is to evaluate whether short-term dietary interventions can improve cardiometabolic risk factors in patients after myocardial infarction. The study includes adult patients following myocardial infarction.

The main questions it aims to answer are:

  • Does adherence to an ESC-recommended diet lead to improvements in lipid profile and body composition compared with no dietary intervention?
  • Does a plant-based (vegan) diet lead to similar or greater improvements in cardiometabolic parameters compared with the control group? Researchers will compare the ESC diet group and the plant-based diet group with a control group to assess their effects on body mass index, lipid profile, and inflammatory markers.

Participants will:

  • be assigned to one of three groups (ESC diet, plant-based diet, or control),
  • receive dietary counselling according to their assigned group (intervention groups),
  • follow the assigned dietary pattern for 3 months,
  • undergo baseline and follow-up clinical and laboratory assessments, including anthropometric measurements and blood sampling.

Studieoversigt

Detaljeret beskrivelse

This was a single-center, three-arm, controlled, partially randomized interventional pilot study designed to evaluate the feasibility and potential effects of dietary modification in the secondary prevention of myocardial infarction over a three-month period. Participants were recruited between January 2022 and December 2025. The study duration was three months.

Participants who agreed to change their dietary habits were randomized in a 1:1 ratio into two intervention groups using stratified block randomization according to diabetes mellitus status and smoking status. Group A followed a diet based on the recommendations of the European Society of Cardiology (ESC), while Group B adopted a strictly plant-based (vegan) diet.

Patients who declined dietary modification but agreed to undergo study assessments were included as a parallel, non-intervention control group (Group C), based on patient preference.

All participants underwent clinical and laboratory assessments at baseline and at three months, including body composition analysis using bioimpedance (InBody). In the intervention groups, additional scheduled visits were conducted at monthly intervals during the three-month period. At these visits, participants received nutritional counseling from a registered dietitian and completed a three-day dietary record to assess dietary intake and adherence. Participants were additionally allowed to contact the dietitian or the study physician outside the scheduled visits if needed.

Laboratory analyses included lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, lipoprotein(a), triglycerides), glycemic parameters (fasting blood glucose, glycated hemoglobin HbA1c), inflammatory markers (high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6)), vitamin B12, vitamin D, iron metabolism, complete blood count, and basic biochemical parameters.

Patient recruitment was conducted in collaboration with the coronary care unit of St. Anne's University Hospital Brno (FNUSA). Nutritional counselling was delivered by trained Master's degree nutrition therapy students from the Faculty of Medicine, Masaryk University.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

24

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Brno, Tjekkiet, 62500
        • Masaryk university

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Myocardial Infarction First

Exclusion Criteria:

  • Myocardial Infarction Second
  • Age under 18

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Plant based diet
The intervention arm, in which participants switch to a strictly plant-based (vegan) diet for three months.
Change dietary habits for tree months
Eksperimentel: Diet based on the recommendations of the European Society of Cardiology
The intervention arm, in which participants switch to a diet based on the recommendations of the European Society of Cardiology for three months.
Change dietary habits for tree months
Ingen indgriben: Control arm
Patients who declined dietary modification but agreed to undergo study assessments were included as a parallel, non-intervention control group.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Percentage of participants enrolled in the study
Tidsramme: 48 months
In percentage terms, the number of patients contacted and the proportion of those who were subsequently enrolled.
48 months
Percentage of participants completed the study
Tidsramme: 3 month
Percentage of the enrolled patients completed the study.
3 month

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Changes in weight after diet changes
Tidsramme: 3 months
Change from baseline InBody - bioelectrical impedance analysis Unit: kg
3 months
Changes in viceral fat area after diet changes
Tidsramme: 3 month
Change from baseline. InBody - bioelectrical impedance analysis Unit: cm3
3 month
Changes in skeletal muscle mass after diet changes
Tidsramme: 3 month
Change from baseline InBody - bioelectrical impedance analysis Unit: kg
3 month
Changes in body fat mass after diet changes
Tidsramme: 3 month
Change in baseline InBody - bioelectrical impedance analysis Unit: kg
3 month
Changes in total body water after diet changes
Tidsramme: 3 month
Change from baseline InBody - bioelectrical impedance analysis Unit: litr
3 month
Changes in body mass index after diet changes
Tidsramme: 3 month
Change from baseline InBody - bioelectrical impedance analysis Unit: kg/m2
3 month
Changes in glycated hemoglobin after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/mol
3 month
Changes in potassium after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month
Changes in magnesium after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month
Changes in iron after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month
Changes in fasting glucose after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month
Changes in total cholesterol after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month
Changes in LDL-cholesterol after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month
Changes in HDL-cholesterol after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month
Changes in triglycerides after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month
Changes in lipoprotein(a) after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: nmol/l
3 month
Changes in IL-6 after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: ng/l
3 month
Changes in hsCRP after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mg/l
3 month
Changes in vitamin B12 after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: pmol/l
3 month
Changes in 25-hydroxyvitamin D after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: nmol/l
3 month
Changes in ferritin after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: ug/l
3 month
Changes in transferin after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: g/l
3 month
Changes in hemoglobin after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: g/l
3 month
Changes in body fat after diet changes
Tidsramme: 3 month
Change from baseline InBody - bioelectrical impedance analysis Unit: %
3 month
Changes in calcium after diet changes
Tidsramme: 3 month
Change from baseline Blood test Unit: mmol/l
3 month

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

20. januar 2022

Primær færdiggørelse (Faktiske)

1. december 2025

Studieafslutning (Faktiske)

1. december 2025

Datoer for studieregistrering

Først indsendt

8. april 2026

Først indsendt, der opfyldte QC-kriterier

4. maj 2026

Først opslået (Faktiske)

8. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

8. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

4. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

This is a pilot academic study; there is no need to share the IPD with other researchers.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Myokardieinfarkt først

Kliniske forsøg med Plant based diet

Abonner